Illinois Eye Center
Peoria, Illinois, United States
Eye care center in Peoria, Illinois
8921 Wood Sage Rd, Peoria, IL 61615
About Illinois Eye Center
"Our dedicated staff, specialized team of caregivers, fellowship-trained physicians and sub-specialists are committed to improving, maintaining and enhancing your quality of visual health."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
2
IVERIC bio, Inc.
1
Ophthotech Corporation
1
Pfizer
1
Unity Biotechnology, Inc.
1
Clinical Trials at Illinois Eye Center
During the past decade, Illinois Eye Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
2016-10-13
2022-11-10
Completed
702
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
2017-03-27
2019-05-13
Terminated
219
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
2017-03-29
2018-10-01
Completed
753
ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)
2017-10-11
2018-10-18
Completed
64
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
2020-06-22
2023-07-01
Active, not recruiting
448
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
2022-03-02
2023-08-01
Active, not recruiting
51
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Illinois Eye Center" #1 sponsor was "Shire" with 2 trials, followed by "IVERIC bio, Inc." with 1 trials
sponsored, "Ophthotech Corporation" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Unity Biotechnology, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Eye Center"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Illinois Eye Center
According to Clinical.Site data, the most researched conditions in "Illinois Eye Center" are
"Adenoviral Conjunctivitis" (1 trials), "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Geographic Atrophy" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Illinois Eye Center" in a lesser frequency.
Clinical Trials Intervention Types at Illinois Eye Center
Most popular intervention types in "Illinois Eye Center" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials), "Zimura" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Illinois Eye Center
The vast majority of trials in "Illinois Eye Center" are
6 trials for "All" genders.
Clinical Trials Status at Illinois Eye Center
Currently, there are NaN active trials in "Illinois Eye Center".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Illinois Eye Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois Eye Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".